Written by: Wenlan (Wendy) Zhang, MD October 2021 Lauermann P, Klingelhöfer A, Mielke D, van Oterendorp C, Hoerauf H, Striebe NA, Storch MW, Pfeiffer S, Koscielny J, Sucker C, Bemme S, Feltgen N. Risk Factors for Severe Bleeding Complications in Vitreoretinal Surgery and the Role of Antiplatelet or Anticoagulant Agents. Ophthalmol Retina. 2021 Aug;5(8):e23-e29. Many […]
Written by: Musa Abdelaziz, MD October 2021 Fang, Y et al. “Development of macular atrophy after pars plana vitrectomy for myopic traction maculopathy and macular hole retinal detachment in pathologic myopia.” Retina. 2020 Oct;40(10):1881-1893. DOI: 10.1097/IAE.0000000000002709. Pathologic myopia (PM) is a major cause of legal blindness worldwide. The most serious lesion associated with severe vision […]
Written by: Philip P. Storey, MD October 2021 Khanani A, Callanan D, Dreyer R, Chen S, Howard J, Hopkins J, Lin C, Lorenz-Candlin M, Makadia S, Patel S, Tam T, Gune S. End-of-Study Results for the Ladder Phase 2 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration. Ophthalmology Retina 2021;5:775-787. […]
Written by: Daniel Su, MD October 2021 Soares RR, Mahmoudzadeh R, Salabati M, Massenzio E, Israilevich R, Patel SN, Hinkle J, Kuriyan AE, Hsu J, Garg SJ, Khan MA. Epiretinal Membrane Surgery after Retinal Detachment Repair: Visual Acuity Outcomes and OCT Analysis. Ophthalmol Retina. 2021 Mar 29:S2468-6530(21)00103-2. Epiretinal membrane (ERM) formation commonly occurs after primary […]
Written by: Edward H. Wood, MD September 2021 Lee Dong Hyun, Sung Eun Park, and Christopher Seungkyu Lee. 2020. “Microcystic Macular Edema and Cystoid Macular Edema Before and After Epiretinal Membrane Surgery.” Retina Publish Ahead of Print (December). https://doi.org/10.1097/IAE.0000000000003087. This study is clinically useful by expanding our understanding of imaging biomarkers of idiopathic epiretinal membranes (ERM) […]
Written by: Mohsin H. Ali, MD September 2021 Gallardo, Mathias, et al. “Machine Learning Can Predict Anti–VEGF Treatment Demand in a Treat-and-Extend Regimen for Patients with Neovascular AMD, DME, and RVO Associated Macular Edema.” Ophthalmology Retina, vol. 5, no. 7, 2021, pp. 604–624., doi:10.1016/j.oret.2021.05.002. Machine learning artificial intelligence models have the potential to improve our […]
Written by: Akshay S. Thomas, MD August 2021 Khurana RN, Kunimoto D, Yoon YH, et al. Two-year results of the phase 3 randomized controlled study of abicipar in neovascular age-related macular degeneration. Ophthalmology. 2021;128(7):1027-1038. Treatment options for wet AMD in 2019 included off-label use of bevacizumab or use of an FDA-approved agent, ranibizumab or […]
Written by: Vlad Matei, MD August 2021 Spooner K, Fraser-Bell S, Hong T, et al. Long-term anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration: the LATAR study. Report 1: ten-year, real-world outcomes. Ophthalmology Retina 2021;5(6):511-518. Neovascular age-related macular degeneration (nAMD) is one of the most common and debilitating diseases encountered by retinal specialists. […]
